Teladoc (TDOC) Health announced that it has signed a definitive agreement to acquire Catapult Health, a leading provider of virtual preventive care services. The company plans to leverage Catapult Health’s innovative approach to patient-centric at-home diagnostic testing, as well as its high-touch engagement and clinical support model, to complement Teladoc Health’s industry-leading suite of integrated solutions. Teladoc Health has signed a definitive agreement to acquire Catapult Health in an all-cash transaction for $65 million, with up to $5 million in additional contingent earnout consideration. Catapult Health’s trailing twelve-month revenue was approximately $30 million as of the third quarter of 2024. The transaction is expected to close in the first quarter of 2025, subject to customary closing conditions.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc call volume above normal and directionally bullish
- Teladoc price target raised to $12 from $11 at RBC Capital
- Teladoc price target lowered to $10.50 from $11.50 at BofA
- Study shows online therapy boom mostly benefited priviledged groups, NYT says
- Lilly cuts FY24 outlook, United Rentals to acquire H&E: Morning Buzz